Ken Griffin Surface Oncology, Inc. Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.61 - $1.03 $300,458 - $507,331	-492,555 Reduced 80.59%	118,652 $83,000
Q4 2022 Feb 14, 2023	SELL	$0.62 - $1.21 $483,617 - $943,835	-780,029 Reduced 56.07%	611,207 $501,000
Q3 2022 Nov 14, 2022	BUY	$1.05 - $2.1 $12,484 - $24,969	11,890 Added 0.86%	1,391,236 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$1.42 - $3.15 $36,735 - $81,490	-25,870 Reduced 1.84%	1,379,346 $2.26 Million
Q1 2022 May 16, 2022	SELL	$2.65 - $5.08 $97,573 - $187,045	-36,820 Reduced 2.55%	1,405,216 $4.13 Million
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $73,821 - $123,295	-15,607 Reduced 1.07%	1,442,036 $6.89 Million
Q3 2021 Nov 15, 2021	SELL	$5.16 - $7.98 $1.77 Million - $2.74 Million	-343,445 Reduced 19.07%	1,457,643 $11 Million
Q2 2021 Aug 16, 2021	BUY	$6.45 - $9.09 $5.52 Million - $7.77 Million	855,239 Added 90.42%	1,801,088 $13.4 Million
Q1 2021 May 17, 2021	BUY	$7.25 - $13.82 $6.43 Million - $12.3 Million	887,474 Added 1520.3%	945,849 $7.38 Million
Q4 2020 Feb 16, 2021	BUY	$6.87 - $10.48 $401,036 - $611,770	58,375 New	58,375 $539,000
Q2 2020 Aug 14, 2020	SELL	$1.57 - $6.56 $442,944 - $1.85 Million	-282,130 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$1.44 - $3.95 $2,109 - $5,786	-1,465 Reduced 0.52%	282,130 $528,000
Q4 2019 Feb 14, 2020	BUY	$1.17 - $2.33 $1,100 - $2,192	941 Added 0.33%	283,595 $533,000
Q3 2019 Nov 14, 2019	SELL	$1.4 - $2.84 $20,253 - $41,086	-14,467 Reduced 4.87%	282,654 $401,000
Q2 2019 Aug 14, 2019	SELL	$2.75 - $4.89 $417,208 - $741,871	-151,712 Reduced 33.8%	297,121 $838,000
Q1 2019 May 15, 2019	SELL	$4.11 - $5.88 $1.01 Million - $1.45 Million	-245,961 Reduced 35.4%	448,833 $0
Q4 2018 Feb 14, 2019	SELL	$3.65 - $10.69 $1.33 Million - $3.89 Million	-363,458 Reduced 34.35%	694,794 $2.95 Million
Q3 2018 Nov 13, 2018	BUY	$8.92 - $17.83 $1.72 Million - $3.43 Million	192,533 Added 22.24%	1,058,252 $0
Q2 2018 Aug 10, 2018	BUY	$12.83 - $17.41 $11.1 Million - $15.1 Million	865,719 New	865,719 $0

Others Institutions Holding SURF

# of Institutions

Shares Held

315K

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

171K
Shares

$0
0.24% of portfolio
Kingsbury Capital Investment Advisors LLC Evanston, IL

144K
Shares

$0
0.23% of portfolio

View Full List

About Surface Oncology, Inc.

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

More about SURF

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account